Atlas Trials

PRIME: Panitumumab Randomized Trial In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy

Clinical trial NCT00364013 · COMPLETED

Trial details

NCT number
NCT00364013
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Metastatic Colorectal Cancer
Start date
2006-08-01
Primary completion
2009-08-01
Enrollment
1183

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.